Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             247 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 153 Accelerated hyperfractionated intensity modulated radiotherapy (AHI) FOR T2-3 oropharyngeal carcinoma: Preliminary results from a phase I-II study Sanguineti, G.
 2006
 78 S1 p. S51-
1 p.
 artikel
2 229 A comparison of helical tomotherapy IMRT, conformal radiation therapy, and step-and-shoot imrt for esophageal cancer Chen, Y.
 2006
 78 S1 p. S81-
1 p.
 artikel
3 128 A comprehensive genomic approach to the identification of predictive markers using dna and tissue repair gene polymorphisms in radiation induced late toxicity in prostate cancer patients treated with conformal radiotherapy Damaraju, S.
 2006
 78 S1 p. S41-
1 p.
 artikel
4 201 A conformal technique for breast irradiation and minimal lung involvement Fogliata, A.
 2006
 78 S1 p. S70-
1 p.
 artikel
5 216 Activation of a DNA repair pathway by the MET RTK—A novel target for tumor radiosensitization Ganapathipillai, S.
 2006
 78 S1 p. S75-S76
2 p.
 artikel
6 110 Activation of RHOS by hypoxia controls HIF-1α stabilization through GSK-3 in glioblastoma Skuli, N.
 2006
 78 S1 p. S35-
1 p.
 artikel
7 230 Advanced radiotherapy techniques for small brain tumours. A comparative study Cozzi, L.
 2006
 78 S1 p. S81-
1 p.
 artikel
8 59 Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas Delaney, T.F.
 2006
 78 S1 p. S21-
1 p.
 artikel
9 260 Alpha/beta ratios for radiosurgical target tissue treated with 200 mev protons Slabbert, I.
 2006
 78 S1 p. S92-
1 p.
 artikel
10 140 A model for the dose response of the spinal cord for irradiated length scales between mm and the whole organ Alber, M.
 2006
 78 S1 p. S46-
1 p.
 artikel
11 171 Analytical quality assurance criteria for ct-mri mutual information image fusion prior to stereotactic radiosurgery treatment planning Barbiere, J.
 2006
 78 S1 p. S58-
1 p.
 artikel
12 135 An heparan-mimetic protects mice from radiation-induced mucositis Mangoni, M.
 2006
 78 S1 p. S44-
1 p.
 artikel
13 129 APCS is a novel candidate gene on chromosome 1 for radiation-induced lung fibrosis Wang, M.
 2006
 78 S1 p. S41-S42
2 p.
 artikel
14 161 A phase I trial of intraprostatic injection of cg7870 and 3d-conformal radiation therapy (3D-CRT) in patients with localized intermediate risk prostate cancer: Integrated oncolytic adenovirus and radiation-mechanisms of interaction Senzer, N.
 2006
 78 S1 p. S54-S55
2 p.
 artikel
15 155 A phase I trial of whole brain radiation therapy and irinotecan in patients with brain metastases: Durable intracranial response with preservation of cognitive functions Chen, A.Y.
 2006
 78 S1 p. S52-
1 p.
 artikel
16 225 A plan intercomparison study for the anisotropic analytical algorithm, the collapsed cone and the pencil beam algorithm for photon dose calculation Fogliata, A.
 2006
 78 S1 p. S79-
1 p.
 artikel
17 15 Apoptosis-enhancing agents and radiotherapy Verheij, M.
 2006
 78 S1 p. S6-
1 p.
 artikel
18 222 Apoptosis modulation from bench to bedside: Radiosensitization by the oral alkylphospholipid perifosine Vink, S.R.
 2006
 78 S1 p. S78-
1 p.
 artikel
19 156 A prospective phase I/II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor micro environment Herrera, F.
 2006
 78 S1 p. S52-S53
2 p.
 artikel
20 11 Assays directed to assess tumor hypoxia in human tumour and their implications as prognostic and predictive assays Nordsmark, M.
 2006
 78 S1 p. S4-S5
2 p.
 artikel
21 23 Assessment of molecular determinants of development and treatment efficacy in radiation induced sarcoma (RIS) — eortc translational research project 01/01 Hohenberger, P.
 2006
 78 S1 p. S8-S9
2 p.
 artikel
22 165 A study of pre-treatment hypoxia and reoxygenation with functional FDG and FMISO pet imaging and its correlation to radiotherapy outcome Thorwarth, D.
 2006
 78 S1 p. S56-
1 p.
 artikel
23 42 ATM and DNA-PK inhibitors: Functional significance, mechanism of action and clinical application Slade, A.
 2006
 78 S1 p. S15-
1 p.
 artikel
24 Author index 2006
 78 S1 p. S95-S99
5 p.
 artikel
25 211 Basic fibroblast growth factor inhibits radiation-induced apoptosis of endothelial cells by inhibiting acid sphingomyelinase activity Truman, J.P.
 2006
 78 S1 p. S74-
1 p.
 artikel
26 25 Biochemical and molecular mechanisms of drug action Catapano, C.V.
 2006
 78 S1 p. S9-S10
2 p.
 artikel
27 79 Biological imaging in adaptive radiation therapy Olsen, D.R.
 2006
 78 S1 p. S28-
1 p.
 artikel
28 143 Biological modification of radiosensitivity by erlotinib in glioblastoma cells depends on the sequence of treatment Herskind, C.
 2006
 78 S1 p. S47-
1 p.
 artikel
29 68 Bone-seeking radiopharmaceuticals in patients with skeletal metastases. clinical experience using alpha-emitting radium-223 Nilsson, S.
 2006
 78 S1 p. S23-S24
2 p.
 artikel
30 228 Breath hold cone beam CT for image guided stereotactic radiotherapy for liver cancer Hawkins, M.A.
 2006
 78 S1 p. S80-
1 p.
 artikel
31 53 Burning issues in cert Saunders, M.I.
 2006
 78 S1 p. S19-
1 p.
 artikel
32 75 Can hypoxia imaging be used to identify patients for tirapazamine-based therapy? Peters, L.
 2006
 78 S1 p. S26-
1 p.
 artikel
33 5 Can IMRT reduce margins? Bonfeld, T.
 2006
 78 S1 p. S2-
1 p.
 artikel
34 61 Carbon ions in GERMANY: Present and future Debus, J.
 2006
 78 S1 p. S22-
1 p.
 artikel
35 181 Cell adhesion to fibronectin strongly attenuates pharmacological egf-receptor tyrosine kinase inhibition in an integrin-linked kinase-independent manner Eke, I.
 2006
 78 S1 p. S62-S63
2 p.
 artikel
36 233 Cellular and molecular characterisation of radiosensitive cell line lbooos Loong, S.
 2006
 78 S1 p. S82-S83
2 p.
 artikel
37 54 CERT vs late response in normal tissues: Ambushes or good news? Denham, J.W.
 2006
 78 S1 p. S19-S20
2 p.
 artikel
38 106 Characterization of human squamous cell head and neck carcinoma xenografts using 18F-FLT and 18F-MISO autoradiography and immunohistochemistry Bussink, J.
 2006
 78 S1 p. S33-
1 p.
 artikel
39 52 Chemo-radiation vs altered fractionation in head & neck cancer patients: How, when, for whom? Bourhis, I.
 2006
 78 S1 p. S19-
1 p.
 artikel
40 6 Clinical implementation of IMRT: Will it work? Nutting, C.M.
 2006
 78 S1 p. S2-S3
2 p.
 artikel
41 259 Clinical radiosensitivity and metallothione in expression in esophageal carcinoma Nomiya, T.
 2006
 78 S1 p. S92-
1 p.
 artikel
42 38 Clinical status of keratinocyte growth factor Brizel, D.M.
 2006
 78 S1 p. S14-
1 p.
 artikel
43 83 Clinical trials combining oncolytic viral therapy and suicide gene therapy with conformalradiotherapy Freytag, S.
 2006
 78 S1 p. S29-S30
2 p.
 artikel
44 231 Combination of lovastatin and X-Irradiation decreases clonogenicity, cell number, and induces changes in the cell cycle of U87 human malignant glioma cells Gabrys, D.
 2006
 78 S1 p. S82-
1 p.
 artikel
45 107 Comparison of 18F-MISO autoradiography with immunohistochemistry after modification of hypoxia in human glioma and squamous cell xenografts Troost, E.G.C.
 2006
 78 S1 p. S33-S34
2 p.
 artikel
46 103 Comparison of 18FMISO pet and polarographic oxygen electrode measurements in human tumours Buus, S.
 2006
 78 S1 p. S32-
1 p.
 artikel
47 148 Complementary in vitro and in vivo study of the promising combined treatment modality of ionizing radiation and patupilone (EP0906, epothilone B) Hofstetter, B.
 2006
 78 S1 p. S49-S50
2 p.
 artikel
48 4 Concurrent angiogenic and EGFR blockade in conjunction with curative intent chemoradiation for locally advanced head and neck cancer Brizel, D.
 2006
 78 S1 p. S2-
1 p.
 artikel
49 33 Cone-beam CT: Applications in image-guidance Jaffray, D.A.
 2006
 78 S1 p. S12-
1 p.
 artikel
50 115 Conformal radiobiology — clinical gains from ‘safe’ hypofractionation Nahum, A.
 2006
 78 S1 p. S36-S37
2 p.
 artikel
51 118 Conformal therapy as a mean to improve treatment therapeutic index for patients with anal canal cancer Vuong, T.
 2006
 78 S1 p. S37-S38
2 p.
 artikel
52 255 Correlating dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) with changes in tumour volume, as a predictor of radiation response in cervix cancer Zahra, M.A.
 2006
 78 S1 p. S90-S91
2 p.
 artikel
53 144 CpG oligodeoxynucleotides (CpG ODNS) are potent enhancers of radio- and chemoresponses of murine tumors Mason, K.A.
 2006
 78 S1 p. S47-S48
2 p.
 artikel
54 247 Critical appraisal of the management of a parasellar meningothelial meningioma Motta, M.
 2006
 78 S1 p. S87-S88
2 p.
 artikel
55 200 3-D Conformal radiotherapy treatment planning for prostate cancer: Better organ definition and less dose to the penile bulb with MRI-based virtual simulation Dipasquale, G.
 2006
 78 S1 p. S69-S70
2 p.
 artikel
56 32 Defining a BRCA1/BRCA2 dependent pathway of DNA repair in human breast cancer Powell, S.N.
 2006
 78 S1 p. S12-
1 p.
 artikel
57 173 Deformable registration and modeling for precision application and assessment of stereotactic body radiotherapy Brock, K.
 2006
 78 S1 p. S59-
1 p.
 artikel
58 139 Delay differential equations and the dose-time dependence of early radiotherapy reactions Fenwick, J.D.
 2006
 78 S1 p. S45-S46
2 p.
 artikel
59 149 Demethylation with 5-azacytidine increases radiation sensitivity of colorectal carcinoma cell lines Ciernik, I.F.
 2006
 78 S1 p. S50-
1 p.
 artikel
60 199 Development of a prostate deformation model to enable accurate registration of endorectal coil magnetic resonance images (ERC-MRI) Hensel, J.
 2006
 78 S1 p. S69-
1 p.
 artikel
61 210 Development of titanium dioxide-DNA nanocomposites for intracellular delivery and radiation-mediated dna scission Woloschak, G.
 2006
 78 S1 p. S73-S74
2 p.
 artikel
62 130 Differential expression of integrin-associated proteins in mast cells of radiation-damaged tissue Haase, M.
 2006
 78 S1 p. S42-
1 p.
 artikel
63 123 Discussion of toxicity and biomarkers in a phase i trial of gefitinib (IRESSATM) in combination with radiation or chemo-radiation for patients with locally advanced head and neck cancer (LAHNC) Raben, D.
 2006
 78 S1 p. S39-
1 p.
 artikel
64 51 DNA damage assays Dikomey, E.
 2006
 78 S1 p. S18-S19
2 p.
 artikel
65 48 DNA damage response in radioresistant gliomas Short, S.C.
 2006
 78 S1 p. S17-S18
2 p.
 artikel
66 40 DNA-DBS repair as a target for radiotherapy Bristow, R.
 2006
 78 S1 p. S14-S15
2 p.
 artikel
67 241 Dose distribution of heavy-ion scanning irradiation simulated for moving target Urakabe, E.
 2006
 78 S1 p. S85-
1 p.
 artikel
68 196 Dosimetric commissioning of a platform for targeted irradiation of small laboratory animals Wong, J.
 2006
 78 S1 p. S68-
1 p.
 artikel
69 17 Early prediction of therapeutic response by non-invasive imaging Aboagye, E.
 2006
 78 S1 p. S7-
1 p.
 artikel
70 227 Electronic submission and review of radiotherapy planning data for NCIC CTG protocols Field, C.
 2006
 78 S1 p. S80-
1 p.
 artikel
71 167 Endorectal mri assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant post-prostatectomy radiotherapy in patients at high-risk for local failure Vees, H.
 2006
 78 S1 p. S57-
1 p.
 artikel
72 28 Erbitux (cetuximab): from bench to bedside, the head & neck example Bernier, J.
 2006
 78 S1 p. S10-S11
2 p.
 artikel
73 250 Estimation of LQ model parameter — repopulation constant (y/a) for normal tissue reactions in head and neck malignancies treated by twice daily fractionated radiotherapy Chougule, A.
 2006
 78 S1 p. S88-S89
2 p.
 artikel
74 236 Evaluation of bioreductive agent-sodium borocaptate-10b hybrid compounds, as 10B-carriers in boron neutron capture therapy Masunaga, S.
 2006
 78 S1 p. S83-S84
2 p.
 artikel
75 138 Experimental studies on amelioration of side effects of radiotherapy by stem cell therapy Rezvani, M.
 2006
 78 S1 p. S45-
1 p.
 artikel
76 214 Exploiting the fanconi anemia pathway in cancer therapy: Molecular targeting of upstream vs. downstream genes Kachnic, L.A.
 2006
 78 S1 p. S75-
1 p.
 artikel
77 44 FDG-PET based software for delineation of the GTV Davis, J.B.
 2006
 78 S1 p. S16-
1 p.
 artikel
78 170 Feasibility study of using an industrial hand-held optical scanner for image-guided radiation therapy Sohn, J.
 2006
 78 S1 p. S58-
1 p.
 artikel
79 202 First experience with intensity modulation for breast patients Nicolini, G.
 2006
 78 S1 p. S70-
1 p.
 artikel
80 244 Fluctuation in speed and amplitude of lung tumor motion detected by real-time tumor-tracking radiotherapy system Onodeara, S.
 2006
 78 S1 p. S86-S87
2 p.
 artikel
81 63 From genomics and biomarkers to molecular imaging for selection and monitoring of chemoradiation therapy Gelovani, J.G.
 2006
 78 S1 p. S22-
1 p.
 artikel
82 18 Functional histological imaging of hypoxia, proliferation and associated signalling pathways van der Kogel, A.
 2006
 78 S1 p. S7-
1 p.
 artikel
83 219 Gamma radiation sensitizes prostate cancer cells to trail Kaddour-Djebbar, I.
 2006
 78 S1 p. S77-
1 p.
 artikel
84 213 Gefitinib radiosensitizes non-small cell lung cancer cells by suppressing cellular dna repair capacity Tanaka, T.
 2006
 78 S1 p. S74-S75
2 p.
 artikel
85 85 Gene-based therapy in prostate cancer Hollywood, D.
 2006
 78 S1 p. S30-
1 p.
 artikel
86 30 Gene expression arrays and normal tissue radiobiology Stewart, F.A.
 2006
 78 S1 p. S11-
1 p.
 artikel
87 195 Gene expression changes in tumours from breast cancer patients receiving radiation therapy Helland, .
 2006
 78 S1 p. S68-
1 p.
 artikel
88 131 Gene expression profile in irradiated and non-irradiated lymphoblastoid cell lines differing in P53 status Zschenker, O.
 2006
 78 S1 p. S42-S43
2 p.
 artikel
89 256 Gene expression profiling in cervical cancer — an exploration of intra-tumor heterogeneity Bachtiary, B.
 2006
 78 S1 p. S91-
1 p.
 artikel
90 193 Genepi-ENTB: The european normal and tumour tissue bank and database Hölscher, T.
 2006
 78 S1 p. S67-
1 p.
 artikel
91 185 Genetic analysis of radioresistance in a human ovarian tumor cell line Lehnert, S.
 2006
 78 S1 p. S64-
1 p.
 artikel
92 257 Genome wide estimation of gene copy numbers in cervical carcinomas: Relationship to gene expression Brovig, S.R.
 2006
 78 S1 p. S91-S92
2 p.
 artikel
93 29 Genome-wide identification of genes in yeast conferring resistance to radiation and anti-cancer drugs Brown, J.M.
 2006
 78 S1 p. S11-
1 p.
 artikel
94 252 Gliasite radiotherapy boost as part of initial treatment of malignant gliomas: A multi-institutional analysis Welsh, J.
 2006
 78 S1 p. S89-S90
2 p.
 artikel
95 234 Gossypol, a small molecule inhibitor of BCL-2, increases radiation-induced cytotoxicity in human prostate and head and neck cancer cells Geldof, A.
 2006
 78 S1 p. S83-
1 p.
 artikel
96 84 Heat shock improves viral vector distribution as evaluated by micropet imaging Li, G.C.
 2006
 78 S1 p. S30-
1 p.
 artikel
97 34 Helical tomotherapy Mackie, T.R.
 2006
 78 S1 p. S12-S13
2 p.
 artikel
98 114 Hypoxia-associated protein expression in prostate cancer Wilson, G.D.
 2006
 78 S1 p. S36-
1 p.
 artikel
99 187 Hypoxia-pet for radiation treatment planning in head and neck cancer Grosu, A.L.
 2006
 78 S1 p. S65-
1 p.
 artikel
100 3 Hypoxia signaling — impact on tumor metabolism, cell survival & cell death Mazure, N.
 2006
 78 S1 p. S1-S2
2 p.
 artikel
101 9 Hypoxic regulation of translation initiation and its impact on gene expression Wouters, B.G.
 2006
 78 S1 p. S4-
1 p.
 artikel
102 71 IGRT of the prostate with mr spectroscopy, 11C-choline and sentinel node imaging Alber, M.
 2006
 78 S1 p. S24-S25
2 p.
 artikel
103 62 Imaging tumor hypoxia Ling, C.C.
 2006
 78 S1 p. S22-
1 p.
 artikel
104 223 Impact of absorption spectroscopy on 2D radiochromic film dosimetry Devic, S.
 2006
 78 S1 p. S78-S79
2 p.
 artikel
105 152 Improvement of esophageal adenocarcinoma cell and xenograft responses to chemoradiation by targeting cyclin-dependent kinases Raju, U.
 2006
 78 S1 p. S51-
1 p.
 artikel
106 1 Improvement of radio(chemo)therapy by molecular-targeting approaches: Focus on cancer cell clonogens (CCCS) Milas, L.
 2006
 78 S1 p. S1-
1 p.
 artikel
107 43 Improving inter- and intra-fraction reproducibility Dawson, L.A.
 2006
 78 S1 p. S15-S16
2 p.
 artikel
108 55 IMRT, second cancers, and the special case of children Hall, E.
 2006
 78 S1 p. S20-
1 p.
 artikel
109 20 Inaugural eortc session lecture: New hypoxia targets in the arena Stratford, I.J.
 2006
 78 S1 p. S7-
1 p.
 artikel
110 147 Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of PKB/AKT-mediated survival signalling Rübel, A.
 2006
 78 S1 p. S49-
1 p.
 artikel
111 158 Increased toxicity with gefitinib, capecitabine and radiation in pancreatic and rectal cancer: phase I trial results Czito, B.
 2006
 78 S1 p. S53-S54
2 p.
 artikel
112 77 Individualizing and adapting treatment delivery: the liver model Dawson, L.A.
 2006
 78 S1 p. S27-
1 p.
 artikel
113 134 Induction of radiation-induced pneumonitis relies on the CD95/CD95-L system Heinzelmann, F.
 2006
 78 S1 p. S43-S44
2 p.
 artikel
114 111 Influence of hypoxia on the expression of VEGF and components of the plasminogen activation system (PAS) in squamous cell carcinoma (SCC) cell lines Bayer, C.M.
 2006
 78 S1 p. S35-
1 p.
 artikel
115 226 Integral dose conservation in radiotherapy Curle, C.
 2006
 78 S1 p. S79-S80
2 p.
 artikel
116 113 β1-integrin or integrin-linked kinase overexpression promotes radiation-induced apoptosis in human HL60 leukemia cells Hess, F.
 2006
 78 S1 p. S36-
1 p.
 artikel
117 182 β1-integrins in cell adhesion-mediated radioresistance: First emerging insights Cordes, N.
 2006
 78 S1 p. S63-
1 p.
 artikel
118 204 Intensity modulated photon (IMXT) and proton (IMPT) therapy for the treatment of head and neck tumors Steneker, M.N.J.
 2006
 78 S1 p. S71-
1 p.
 artikel
119 126 Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node optimized target volume definition Ganswindt, U.
 2006
 78 S1 p. S40-S41
2 p.
 artikel
120 101 Interrelation of polarographically measured oxygenation levels, erythropoietin and erythropoietin receptor expression in spontaneous canine tumors Rohrer Bley, C.
 2006
 78 S1 p. S31-
1 p.
 artikel
121 10 Interstitial fluid pressure and hypoxia: Impact on treatment outcome and metastatic development Hill, R.P.
 2006
 78 S1 p. S4-
1 p.
 artikel
122 14 Intra-operative radiotherapy (IORT) in early breast cancer Orecchia, R.
 2006
 78 S1 p. S6-
1 p.
 artikel
123 197 Introduction of image-guided adaptive radiotherapy techniques Field, C.
 2006
 78 S1 p. S68-S69
2 p.
 artikel
124 237 Investigation of plasminogen activator inhibitor-1 (PAI-1) as an endogenous hypoxia marker in human head and neck carcinoma cell lines Schilling, D.
 2006
 78 S1 p. S84-
1 p.
 artikel
125 215 In vitro and in vivo effects after combined treatment of colorectal tumors with apoptosis inducing trail receptor antibodies hgs-etr1 and HGS-ETR2 and radiotherapy Marini, P.
 2006
 78 S1 p. S75-
1 p.
 artikel
126 245 Ionizing radiation as an experimental tool in studies of adult neurogenesis in mammalian brain Woitowicz, J.M.
 2006
 78 S1 p. S87-
1 p.
 artikel
127 121 Is expression of the epidermal growth factor receptor related to hypoxia in squamous cell carcinomas of the head and neck - an evaluation of the dahanca 5 study Eriksen, J.G.
 2006
 78 S1 p. S38-S39
2 p.
 artikel
128 50 Is tumor radiosensitivity predictable? Begg, A.
 2006
 78 S1 p. S18-
1 p.
 artikel
129 192 Long-term performance of hypoxia an;, IFP as prognostic factors in cervix cancer Fyles, A.
 2006
 78 S1 p. S67-
1 p.
 artikel
130 41 Low-dose hypersensitivity: Biological mechanism Joiner, M.C.
 2006
 78 S1 p. S15-
1 p.
 artikel
131 12 LOX is essential for hypoxia-induced metastasis Erler, J.T.
 2006
 78 S1 p. S5-
1 p.
 artikel
132 151 Mechanisms of parthenolide-induced radiosensitization of NFkB activated CGL1 (Hela hybrid) cells Mendonca, M.S.
 2006
 78 S1 p. S50-S51
2 p.
 artikel
133 36 Messages from metastases Withers, H.R.
 2006
 78 S1 p. S13-
1 p.
 artikel
134 46 Micro-array profiles in predicting tumor outcome Bartelink, H.
 2006
 78 S1 p. S17-
1 p.
 artikel
135 190 Microenvironment of brain tumors: Hypoxia, proliferation and vasculature Evans, S.M.
 2006
 78 S1 p. S66-
1 p.
 artikel
136 179 Microsatellite alterations in head and neck squamous cell carcinoma: comparison of the sensitivity of a novel literature-based microsatellite panel versus the bethesda reference panel De Schutter, H.
 2006
 78 S1 p. S61-S62
2 p.
 artikel
137 109 Microsatellite alterations (MSI/LOH) in head and neck squamous cell carcinoma: Does a correlation exist with hypoxia as measured by pimonidazole? De Schutter, H.
 2006
 78 S1 p. S34-
1 p.
 artikel
138 67 Modeling clinical applications or radioimmunotherapy: Targeting the HER2 antigen Brechbie, M.W.
 2006
 78 S1 p. S23-
1 p.
 artikel
139 119 Modification of brain tumor microenvironment by spinal cord stimulation Clavo, B.
 2006
 78 S1 p. S38-
1 p.
 artikel
140 64 Molecular imaging for translational research in radiation oncology Price, P.
 2006
 78 S1 p. S22-
1 p.
 artikel
141 177 Molecular markers for lymph node involvement in advanced cervical carcinomas Lyng, H.
 2006
 78 S1 p. S60-S61
2 p.
 artikel
142 27 Molecular modulation of the tumor vasculature — Impact on tumor response to radiation therapy Siemann, D.W.
 2006
 78 S1 p. S10-
1 p.
 artikel
143 24 Molecular profiles of gliomas, mechanistic insights and associations with outcome Murat, A.
 2006
 78 S1 p. S9-
1 p.
 artikel
144 169 Multimodal contrast agent for radiation therapy planning and guidance Zheng, J.
 2006
 78 S1 p. S57-S58
2 p.
 artikel
145 69 Multi-modality imaging for target volume delineation in HNSCC Grégoire, V.
 2006
 78 S1 p. S24-
1 p.
 artikel
146 117 Negative post-treatment 18-FDG pet scans may not predict pathologic complete response in patients with rectal cancer undergoing neoadjuvant chemoradiation Konski, A.
 2006
 78 S1 p. S37-
1 p.
 artikel
147 82 New predictors of treatment outcome: what the RTOG trials have taught us Pollack, A.
 2006
 78 S1 p. S29-
1 p.
 artikel
148 13 New radiotherapy strategies in breast cancer: Partial breast radiotherapy Yarnold, J.
 2006
 78 S1 p. S5-
1 p.
 artikel
149 39 Normal tissue countermeasures Coleman, C.N.
 2006
 78 S1 p. S14-
1 p.
 artikel
150 37 Normal tissue protection Dörr, W.
 2006
 78 S1 p. S13-S14
2 p.
 artikel
151 76 Novel biology, new technology, same ol' clinical practice? Bentzen, S.M.
 2006
 78 S1 p. S26-S27
2 p.
 artikel
152 49 Novel chemo-radiotherapy approaches in treating high-grade glioma Mirimanoff, R.O.
 2006
 78 S1 p. S18-
1 p.
 artikel
153 220 On-line tumor perfusion measurement with contrast enhanced cone beam CT Yeung, I.
 2006
 78 S1 p. S77-S78
2 p.
 artikel
154 239 On the absolute dose calibration of the pvass00 portal imager from varian. Application to IMRT verification Nicolini, G.
 2006
 78 S1 p. S84-S85
2 p.
 artikel
155 35 On the use of 3D-ultrasound localization systems for in room imaging Tomé, W.
 2006
 78 S1 p. S13-
1 p.
 artikel
156 164 Optical-computed-and emission tomography: A new imaging modality for cancer research Oldham, M.
 2006
 78 S1 p. S55-S56
2 p.
 artikel
157 22 Optimization of the treatment modality combining ionizing radiation with inhibitors of angiogenesis Pruschy, M.
 2006
 78 S1 p. S8-
1 p.
 artikel
158 172 Patient dose due to electronic portal imaging Bezak, E.
 2006
 78 S1 p. S58-S59
2 p.
 artikel
159 208 Pescadillo and CYP1B1: Novel metabolic targets in glioma Brooks, S.
 2006
 78 S1 p. S72-S73
2 p.
 artikel
160 163 Phase I clinical trial of N-nitro-L-arginine (LNNA): Pharmacokinetics, toxicities and effects on microregional blood flow Ng, Q.S.
 2006
 78 S1 p. S55-
1 p.
 artikel
161 176 P27 is a molecular tumor marker prognostic for survival in 118 NSCLC patients (PTS) treated with radiation t chemotherapy on ECOG3590 Martin, N.E.
 2006
 78 S1 p. S60-
1 p.
 artikel
162 175 Polymorphism at the 3′-utr of the thymidylate synthase (tyms) gene, a potential predictor for outcomes: Of patient with esophageal adenocarcinoma treated with preoperative chemoradiation Liao, Z.
 2006
 78 S1 p. S60-
1 p.
 artikel
163 45 Precision in patient models: How much is required to meet which clinical goals? Ten Haken, R.K.
 2006
 78 S1 p. S16-S17
2 p.
 artikel
164 26 Preclinical evaluation of molecular targeted approaches Baumann, M.
 2006
 78 S1 p. S10-
1 p.
 artikel
165 102 Preclinical studies in murine tumours to elucidate the role of serum osteopontin as an endogenous marker of hypoxia Lukacova, S.
 2006
 78 S1 p. S31-
1 p.
 artikel
166 249 Prediction of radiotherapy or chemoradiotherapy efficacy in patients with breast or bladder cancer Ivanov, S.D.
 2006
 78 S1 p. S88-
1 p.
 artikel
167 159 Preliminary results of a phase I study of external beam radiation therapy (EBRT), oxaliplatin (OX), bevacizumab (BV), and capecitabine (CAP) for locally advanced or metastatic adenocarcinoma of the rectum Czito, B.
 2006
 78 S1 p. S54-
1 p.
 artikel
168 154 Preliminary results of dose escalation in laryngeal and hypopharyngeal cancer with intensity modulated radiotherapy (IMRT) Guerrero Urbano, T.
 2006
 78 S1 p. S51-S52
2 p.
 artikel
169 122 Prognostic value of gross tumor volume (GTV) in head and neck cancer treated with IMRT Studer, G.
 2006
 78 S1 p. S39-
1 p.
 artikel
170 232 Proliferating cell nuclear antigene (PCNA)-protein induction in lymphoid tissues of radioensitive “wasted” mice Paunesku, T.
 2006
 78 S1 p. S82-
1 p.
 artikel
171 186 Proteomics of human brain tumors Sminia, P.
 2006
 78 S1 p. S64-S65
2 p.
 artikel
172 116 Proton therapy at PSI for soft tissue tumours in childhood Timmermann, B.
 2006
 78 S1 p. S37-
1 p.
 artikel
173 7 Proton therapy versus photon-based IMRT: Is the difference clinically relevant? Aovama, H.
 2006
 78 S1 p. S3-
1 p.
 artikel
174 206 Quality assurance in radiation oncology: Validation of methods and monitoring process to reduce errors and dysfunctions (quaraton) Casciaro, E.
 2006
 78 S1 p. S71-S72
2 p.
 artikel
175 242 Quantitative evaluation of 3d lung motion with anatomical feature tracking technique for precise particle radiotherapy Tashiro, M.
 2006
 78 S1 p. S85-S86
2 p.
 artikel
176 133 Radiation-induced damage to mouse urothelial barrier Jaal, J.
 2006
 78 S1 p. S43-
1 p.
 artikel
177 178 Radiation-induced up-regulation of CXCR4 is counteracted by association of irradiation with cidofovir Amine, A.
 2006
 78 S1 p. S61-
1 p.
 artikel
178 162 Radiation inducible gene therapy with TNFerade — local activation with systemic potential: Pancreas protocol dose-escalation assessment and immune rationale Senzert, N.
 2006
 78 S1 p. S55-
1 p.
 artikel
179 31 Radiation responsive genes in glioma cells Short, S.C.
 2006
 78 S1 p. S11-S12
2 p.
 artikel
180 261 Radiation therapy in a homogenous group of head and neck cancer patients - an examination of prognostic factors Silva, P.
 2006
 78 S1 p. S92-S93
2 p.
 artikel
181 66 Radioantibodies: Monoclonals or “poly-clonals”? Paganelli, G.
 2006
 78 S1 p. S23-
1 p.
 artikel
182 188 Radiobiological modelling of the interplay between accelerated repopulation and altered fractionation schedules in head and neck cancers Marcu, L.
 2006
 78 S1 p. S65-
1 p.
 artikel
183 198 Radiographic respiratory gating for lung radiotherapy without internal fiducials Korreman, S.S.
 2006
 78 S1 p. S69-
1 p.
 artikel
184 221 Radiosensitisation of tumour cells by the HIV-1 TAT protein Yi, S.
 2006
 78 S1 p. S78-
1 p.
 artikel
185 146 Radiosensitization of prostate cancer by genistein in vitro and in an orthotopic model in vivo Hillman, G.G.
 2006
 78 S1 p. S48-S49
2 p.
 artikel
186 47 Radiotherapy of breast cancer — Predicting normal tissue reactions? Overqaard, J.
 2006
 78 S1 p. S17-
1 p.
 artikel
187 80 Radiotherapy of organ-confined prostate cancer: Biochemical failure definitions and risk groups Thames, H.
 2006
 78 S1 p. S28-
1 p.
 artikel
188 174 Re-assessment of hnscc tumor volume during radiotherapy with anatomic and functional imaging Geets, X.
 2006
 78 S1 p. S59-S60
2 p.
 artikel
189 78 Recent advances in image-guided radiotherapy Mohan, R.
 2006
 78 S1 p. S27-S28
2 p.
 artikel
190 60 Recent developments of light ion therapy Brahme, A.
 2006
 78 S1 p. S21-S22
2 p.
 artikel
191 203 Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer Korreman, S.S.
 2006
 78 S1 p. S70-
1 p.
 artikel
192 212 Residual gamma-H2AX as a measure of response to single and fractionated doses of ionizing radiation Olive, P.L.
 2006
 78 S1 p. S74-
1 p.
 artikel
193 254 Selected molecular, histological and clinical factors influencing prognosis and predictive for patients with advanced head and neck cancer (HNSCC) irradiated after induction chemotherapy(CT) Malecki, K.
 2006
 78 S1 p. S90-
1 p.
 artikel
194 74 Selective radioprotection of normal tissue by Bowman-Birk proteinase inhibitor Dittmann, K.
 2006
 78 S1 p. S25-S26
2 p.
 artikel
195 262 Should pet scanning be routinely used in the imaging of patients with a neck node from an unknown squamous primary? Silva, P.
 2006
 78 S1 p. S93-
1 p.
 artikel
196 238 Significance of reference in tumour gene expression analyses by c-DNA array Laytragoon-Lewin, N.
 2006
 78 S1 p. S84-
1 p.
 artikel
197 251 Significance of serum copper, zinc and copper/zinc ratio in cancer head & neck and cancer cervix uterus treated by radiotherapy Arun, C.
 2006
 78 S1 p. S89-
1 p.
 artikel
198 136 Simultaneous normal tissue protection and increased tumor radiosensitivity : A new goal for pravastatin? Haydont, V.
 2006
 78 S1 p. S44-S45
2 p.
 artikel
199 258 Some radiobiological considerations on the potential of imrt in non-standard fractionation Calandrino, R.
 2006
 78 S1 p. S92-
1 p.
 artikel
200 8 Spot-scanning proton radiation therapy: Clinical experience at PSI Goitein, G.
 2006
 78 S1 p. S3-S4
2 p.
 artikel
201 58 Spot scanning proton therapy: Treatment planning and treatment verification Lomax, A.J.
 2006
 78 S1 p. S21-
1 p.
 artikel
202 112 Stroma irradiation promotes tumor invasion and metastasis through suppression of angiogenesis and selection of highly invasive tumor cells Monnier, Y.
 2006
 78 S1 p. S35-
1 p.
 artikel
203 73 Tailoring molecular radiosensitizers Bodis, S.
 2006
 78 S1 p. S25-
1 p.
 artikel
204 141 Targeted sub-total irradiation of mouse models for normal tissue complication modeling using a prototype micrort device Hope, A.
 2006
 78 S1 p. S46-
1 p.
 artikel
205 183 Targeting CTLA-4 by its recombinant ligands CD80/CD86: Perspectives towards the development of a novel anti-tumor therapeutic approach Palmisano, G.L.
 2006
 78 S1 p. S63-S64
2 p.
 artikel
206 72 Targeting the cell cycle in combination with radiotherapy or chemotherapy McArthur, G.A.
 2006
 78 S1 p. S25-
1 p.
 artikel
207 57 TCP and NTCP important: Tools or toys? Deasy, J.O.
 2006
 78 S1 p. S20-S21
2 p.
 artikel
208 240 The anisotropic analytical algorithm for photon dose calculation. fundamental characterisation in water Fogliata, A.
 2006
 78 S1 p. S85-
1 p.
 artikel
209 224 The anisotropic analytical algorithm for photon dose calculation. Validation measurements in heterogeneous phantoms Fogliata, A.
 2006
 78 S1 p. S79-
1 p.
 artikel
210 124 The association of the phosphatidylinositol-3-kinase pathway to gleason score, prostate - specific antigen and pathologic stage in prostate cancer Gottschalk, A.R.
 2006
 78 S1 p. S40-
1 p.
 artikel
211 125 The biological significance of longitudinal changes in psa level during and after curative treatment for prostate cancer Denham, J.W.
 2006
 78 S1 p. S40-
1 p.
 artikel
212 65 The contribution of the Gustave Roussy Institute in translational radiation oncology Bourhis, J.
 2006
 78 S1 p. S22-S23
2 p.
 artikel
213 127 The development and evaluation of a decision aid in the treatment of patients with localized prostate cancer Isebaert, S.
 2006
 78 S1 p. S41-
1 p.
 artikel
214 81 The dose factor in prostate cancer radiotherapy Miralbell, R.
 2006
 78 S1 p. S28-S29
2 p.
 artikel
215 157 The effect of cox-2 inhibition on molecular responses of rectal cancer to preoperative chemoradiation in a phase ii randomized, double blind, placebo-controlled clinical trial Debucquoy, A.
 2006
 78 S1 p. S53-
1 p.
 artikel
216 191 The fate of hypoxic (Pimonidazole-labeled) cells in human cervix tumours undergoing chemoradiotherapy Durand, R.
 2006
 78 S1 p. S66-S67
2 p.
 artikel
217 160 The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer Schneider, U.
 2006
 78 S1 p. S54-
1 p.
 artikel
218 263 The impact of PI3K/AKT inhibitor on the radiosensitization of breast cancer cells Fu, S.
 2006
 78 S1 p. S93-
1 p.
 artikel
219 16 The impact of the cellular microenvironment on radiation-induced apoptosis Hunter, A.
 2006
 78 S1 p. S6-S7
2 p.
 artikel
220 132 The micro-environment triggered fibrogenic differentiation in human mesenchyman stem cells Bourgier, C.
 2006
 78 S1 p. S43-
1 p.
 artikel
221 218 The natural product honokiol potentiates radiation sensitization induced by SiRNA ADAM9 knockdown in prostate cancer cells Johnstone, P.
 2006
 78 S1 p. S76-S77
2 p.
 artikel
222 145 The new microtubule-interfering compound mpi-0441138 acts as radiosensitizing agent in cancer cells in vitro Skvortsova, I.
 2006
 78 S1 p. S48-
1 p.
 artikel
223 205 The new proton scanning gantry of PSI: A system designed for impt delivery in the whole body including moving targets Pedroni, E.
 2006
 78 S1 p. S71-
1 p.
 artikel
224 180 The nuclear pore complex is a target in the cellular stress response to ionizing radiation Broggini-Tenzer, A.
 2006
 78 S1 p. S62-
1 p.
 artikel
225 246 The potentials of tomotherapy in simultaneous integrated boost (sib) “mucosa-sparing” irradiation of nasopharinx cancers Fiorino, C.
 2006
 78 S1 p. S87-
1 p.
 artikel
226 104 The prognostic value of pimonidazole & tumor pO2 in human cervix carcinomas after radiation therapy: An international multi-center study Nordsmark, M.
 2006
 78 S1 p. S32-
1 p.
 artikel
227 70 Theragnostic imaging for radiation oncology: Dose-painting by numbers Bentzen, S.M.
 2006
 78 S1 p. S24-
1 p.
 artikel
228 189 The response of head and neck tumours to radiotherapy may be influenced by the interaction between cell proliferation and vascularization Buffa, F.M.
 2006
 78 S1 p. S65-S66
2 p.
 artikel
229 209 The role of proliferating cell nuclear antigen (PCNA) protein in radiation-mediated cleavage of oligonucleotides by titanium dioxide — DNA nanocomposites in vitro Babbo, A.
 2006
 78 S1 p. S73-
1 p.
 artikel
230 253 The role of the schedule of the accelerated multifractionation (AMF) in the primary irradiation and combined treatment of patient with hodgkin's lymphoma (HL) Nikolaeva, E.N.
 2006
 78 S1 p. S90-
1 p.
 artikel
231 2 The use of signal transduction inhibitors with radiation McKenna, W.G.
 2006
 78 S1 p. S1-
1 p.
 artikel
232 21 The use of tissue micro arrays in evaluating the addition of chemotherapy to preoperative radiotherapy in patients with rectal cancer Haustermans, K.
 2006
 78 S1 p. S8-
1 p.
 artikel
233 207 Time dependent activation of the jnk pathway by ionising radiation is associated with different radiosensitivities in canine tumor cell lines Wergin, M.
 2006
 78 S1 p. S72-
1 p.
 artikel
234 194 Translating interesting biology into clinically useful tools — the need for a systematic approach to quality control during the development of predictive assays in radiation oncology Munro, A.
 2006
 78 S1 p. S67-S68
2 p.
 artikel
235 19 Translational research: Transforming the role of biomedical publishing Cox, J.D.
 2006
 78 S1 p. S7-
1 p.
 artikel
236 137 Treatment of radiation enteritis with pravastatin : Role of the rho pathway on CTGF expression Haydont, V.
 2006
 78 S1 p. S45-
1 p.
 artikel
237 142 Tumor irradiation potentiates gene-mediated immunotherapy for induction of a curative cancer vaccine Hillman, G.G.
 2006
 78 S1 p. S46-S47
2 p.
 artikel
238 108 Tumor microenvironment and outcome of fractionated irradiation in different human squamous cell carcinomas (HSCC) growing in nude mice Yaromina, A.
 2006
 78 S1 p. S34-
1 p.
 artikel
239 56 Tumor targeting and tissue protection by IMRT of head and neck (HN) cancer: Current challenges Eisbruch, A.
 2006
 78 S1 p. S20-
1 p.
 artikel
240 217 Tumor therapy with ionizing radiation and death ligands: Efficacy and key molecular determinants Verbrugge, I.
 2006
 78 S1 p. S76-
1 p.
 artikel
241 166 Ultrasonic tissue-typing imaging in detecting and evaluating prostate cancer: In vivo and ex vivo studies vs. wholemount pathology Liu, T.
 2006
 78 S1 p. S57-
1 p.
 artikel
242 248 US, CT or MRI — what is the best method for verify the depth of invasion of bladder cancer recurrences? Startsev, V.Y.
 2006
 78 S1 p. S88-
1 p.
 artikel
243 105 Using 18F-fluoroazomycin arabinoside to non-invasively image hypoxia in human tumour xenografts: A comparative assessment with the eppendorf electrode and pimonidazole binding Busk, M.
 2006
 78 S1 p. S32-S33
2 p.
 artikel
244 235 Valproic acid as a radiation protector in a rat spinal cord damage model Kornguth, D.
 2006
 78 S1 p. S83-
1 p.
 artikel
245 120 Vascular endothelial growth factor-A and poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: Correlation and prognostic significance Onesto, C.
 2006
 78 S1 p. S38-
1 p.
 artikel
246 243 Visualization of dose distribution on the endobronchial surface using virtual bronchoscopy Minohara, S.
 2006
 78 S1 p. S86-
1 p.
 artikel
247 150 Wortmannin, an ihibitor of dna double-strand break rejoining, sensitizes human cells to radiation but protects against the cytotoxic effect of cisplatin: Relevance for radiochemotherapy? Frankenberg-Schwager, M.
 2006
 78 S1 p. S50-
1 p.
 artikel
                             247 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland